CD4+ and CD8+ T cells in acute COVID-19 patients showed a substantial reduction of CXCR3 and CXCR5 expression, irrespective of disease severity, that is recovered upon convalescence (Shuwa et al., 2021). This evidence concerns the gene CXCR3 and COVID-19.